Th1 and Th2 in human IVF pregnancy with allogenic fetus

American Journal of Reproductive Immunology

Volumn 59, Issue 4, 2008, Pages 352-358

  Chernyshov, Victor P ^a   Tumanova, Larisa E ^a   Sudoma, Irina A ^b   Bannikov, Vladimir I ^c  

^a STATE INSTITUTION NATIONAL RESEARCH CENTER FOR RADIATION MEDICINE OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE   (Ukraine)

^b SHUPYK NATIONAL MEDICAL ACADEMY OF POSTGRADUATE EDUCATION   (Ukraine)

^c Clinic Isida IVF   (Ukraine)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CXCR3; CYTOKINE; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CONCEPTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FERTILIZATION IN VITRO; FETUS; FIRST TRIMESTER PREGNANCY; FLOW CYTOMETRY; HUMAN; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; OOCYTE DONATION; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

ADULT; B-LYMPHOCYTES; CYTOKINES; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FETUS; HUMANS; KILLER CELLS, NATURAL; OOCYTE DONATION; PREGNANCY; RECEPTORS, CXCR3; RECEPTORS, CXCR4; TH1 CELLS; TH2 CELLS;

EID: 40949148230     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2007.00578.x     Document Type: Article

References (37)

1. Sauer MV, Kavic SM: Oocytes Rnd embryo donation 2006: reviewing two decades of innovation and controversy. Reprod Biomed Online 2006; 12:153-162.
2. Wegmann TG, Lin H, Guilbert L, Mossmann TR: Bidirectional cytokine interactions in maternal-fetal relationship: Is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14:353-356.
3. Chaouat G, Assal Melani A, Martal J, Raghupathy R, Elliot J, Mossman T, Wegmann TG: IL10 prevents naturally occurring fetal loss in the CBAxDBA/ 2 mating combination is corrected by in vivo injection of IFN-tau. J Immunol 1995; 154:4261-4268.
4. Lin H, Mosman T, Guilbert L, Tuntipopipat S, Wegmann TG: Synthesis of T helper 2-type cytokines at the feto-maternal interface. J. Immunol 1993; 151:4562-4573.
5. Raghupathy R, Makhseed M, Azizieh F, Hassan N, Al-Azemi M, Al-Shamali E: Maternal Th1-and Th2-type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortion. Cell Immunol 1999; 196:122-130.
6. Jenkins C, Roberts J, Wilson R, MacLean MA, Shilito J, Walker JJ: Evidence of a T (H) 1 type response associated with recurrent miscarriage. Fertil Steril 2000; 73:1206-1208.
7. Reinhard G, Noll A, Schlebusch H, Mallmann P, Ruecker AV: Shifts in TH1/ TH2 balance during human pregnancy correlate with apoptotic changes. Biochem Biophys Res Commun 1998; 245:933-938.
8. Russell AS, Johnston C, Chew C, Maksymowych WP: Evidence for reduced Th1 function in normal pregnancy: A hypothesis for remission of rheumatoid arthritis. J Rheumatol 1997; 24:1045-1050.
9. Shimaoka Y, Hidaka Y, Tada H, Nakamura T, Mitsuda N, Morimoto Y, Murata Y, Amino N: Changes in cytokine production during and after normal pregnancy. Am J Reprod Immunol 2000; 44:143-147.
10. Ng SC, Gilman-Sachs A, Thaker P, Beaman KD, Beer AE, Kwak-Kim J: Expression of intracellular Th1 and Th2 cytokines in women with recurrent spontaneous abortion, implantation failures after IVF/ET or normal pregnancy. Am J Reprod Immunol 2002; 48:77-86.
11. Zenclussen AC, Fest S, Busse P, Joachim R, Klapp BF, Arck PC: Questioning the Th1/Th2 paradigm in reproduction: Peripheral levels of IL-12 are down-regulated in miscarriage patients. Am J Reprod Immunol 2002; 48:245-251.
12. Yamada H, Morikawa M, Furuta I, Kato EH, Shimada S, Iwabuchi K, Minakami H: Intravenous immunoglobulin treatment in women with recurrent abortions: Increased cytokine levels and reduced Th1/Th2 lymphocyte ratio in peripheral blood. Am J Reprod Immunol 2003; 49:84-89.
13. Mosmann T, Sad S: The expanding universe of T-cell subsets. Immunol Today 1996; 17:138-146.
14. Romagnani P, Annunziato F, Piccini M, Maggi E, Romagnani S: Th1/Th2 cells, their associated molecules and role in pathophysiology. Eur Cytokine Netw 2000; 11:510-511.
15. + T cells differentiation and bridges central and peripheral functions. J Immunol 2003; 171:2812-2824.
16. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borstti A, Sozzani S, Allavena P, Gray PA, Mantovani A, Sinigaglia F: Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998; 187:129-134.
17. Imai T, Nagira M, Takagi S, Kakizaki M, Nishimura M, Wang J, Gray PW, Matsushima K, Yoshie O: Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 1999; 11:81-88.
18. Kim C, Rott L, Kunkel EJ, Genovese MC, Anrew DP, Wu L, Butcher EC: Rules of chemokine receptor association with T cell polarization in vivo. J Clin Invest 2001; 108:1331-1339.
19. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A: Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998; 187:875-883.
20. Matthiensen L, Ekerfelt C, Berg G, Ernerudh J: Increased numbers of circulating interferon-gamma-and interleukin-4-secreting cells during normal pregnancy. Am J Reprod Immunol 1998; 39:362-367.
21. Tranchot-Diallo J, Gras G, Parnet-Matieu F, Benveniste O, Marce D, Roques P, Milliez J, Chaouat G, Dormont D: Modulations of cytokine expression in pregnant women. Am J Reprod Immunol 1997; 37:215-226.
22. Vassali P: The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992; 10:411-452.
23. Aggarwal BB, Natarajan K: Tumor necrosis factors: Developments during the last decade. Eur Cytokine Netw 1996; 7:93-124.
24. Bouman A, Heineman MJ, Faas MM: Sex hormones and the immune response in humans. Hum Reprod Update 2005; 11:411-423.
25. Mellor AL, Munn DH: Immunology at the Laternal-fetal interface: lessons for T cell tolerance and suppression. Annu Rev Immunol 2000; 18:367-391.
26. 2 production. J Immunol 2003; 170:158-166.
27. Yoshie O, Imai T, Nomiyama H: Chemokines in immunity. Adv Immunol 2001; 78:57-110.
28. Moser B, Loetscher P: Lymphocyte traffic control by chemokines. Nat Immunol 2001; 2:123-128.
29. Farber JM: Mig and IP-10: CXC chemokines that target lymphocytes. J Leukocyte Biol 1997; 61:246-257.
30. Cole KE, Strik CA, Paradis TJ et al.: Interferon-inducible T cell α chemoattractant (I-TAC): A novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med 1998; 187:2009-2021.
31. + T cells from atopic dermatitis patients and healthy subjects: The inhibitory effect of IL-4 on ScAg-induced apoptosis. J Imunol 2003; 171:1102-1108.
32. Dekker GA, Robillard PY, Husley TC: Immune maladaptation in the etiology of preeclampsia: A review of corroborative epidemiologic studies. Obstet Gynecol Surv 1998; 53:377-382.
33. Dekker GA, Sibai BM: The immunology of preeclampsia. Semin Perinatol 1999; 23:24-33.
34. TaIlor RN: Rewiew: immunobiology of preeclampsia. Am J Reprod Immunol 1997; 37:79-86.
35. Darmochawal-Kolarz D, Rolinski J, Leszczynska-Goarzelak B, Oleszuk J: The expressions of intracellular cytokines in the lymphocytes of preeclamptic patients. Am J Reprod Immunol 2002; 48:381-386.
36. Sayto S, Sakai M: Th1/Th2 balance in preeclampsia. J Reprod Immunol 2003; 59:161-173.
37. Jonsson Y, Ruber M, Matthiesen L, Berg G, Nieminen K, Sharma S: Cytokine mapping of sera from women with preeclampsia and normal pregnancies. J Reprod Immunol 2006; 70:83-91.